About Joshua Pinto
Joshua Pinto is a president & CEO, director at Neumora Therapeutics.
Form D filings name Joshua Pinto as a director at Metsera.
Joshua Pinto reports to the SEC as a director or officer of 2 public companies, including Metsera (MTSR).
Joshua Pinto first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Pinto in the role, so the role may have started earlier or lasted longer.
NI
Neumora Therapeutics, Inc.
President & CEO, director
2023 – 2026 · Public company (NMRA)
Key Colleagues at Startups
The people Joshua Pinto works with at each company, as listed on that company's latest Form D.
Metsera, Inc. · Form D, Nov 20, 2024
KB
Kristina Burow
Director
CV
Christopher Visioli
Executive officer
BH
Brian Hubbard
Executive officer
CB
Christopher Bernard
Chief Executive Officer and director
SM
Steven Marso
Executive officer
CM
Clive Meanwell
Director
PB
Paul Berns
Director